Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination

被引:29
|
作者
Zeng, Yi [1 ]
Chen, Xinchun [1 ]
Larmonier, Nicolas [1 ]
Larmonier, Claire [1 ]
Li, Gang [1 ]
Sepassi, Marjan [1 ]
Marron, Marilyn [1 ]
Andreansky, Samita [1 ]
Katsanis, Emmanuel [1 ]
机构
[1] Univ Arizona, Dept Pediat, Steele Childrens Res Ctr, Tucson, AZ 85724 USA
关键词
chaperone/heat shock proteins; NK cell; CML; HUMAN NK CELLS; NF-KAPPA-B; IFN-GAMMA PRODUCTION; INTERFERON-GAMMA; DENDRITIC CELLS; INNATE RESISTANCE; SIGNALING PATHWAY; TUMOR-CELLS; ACTIVATION; MICE;
D O I
10.1002/ijc.22150
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor derived chaperone-rich cell lysate (CRCL) when isolated from tumor tissues is a potent vaccine that contains at least 4 of the highly immunogenic heat shock proteins (HSP) such as HSP70, HSP90, glucose related protein 94 and calreticulin. We have previously documented that CRCL provides both a source of tumor antigens and danger signals triggering dendritic cell (DC) activation. Immunization with tumor derived CRCL elicits tumor-specific T cell responses leading to tumor regression. In the current study, we further dissect the mechanisms by which CRCL simulates the immune system, and demonstrate that natural killer (NK) cells are required for effective antitumor effects to take place. Our results illustrate that CRCL directly stimulates proin-flammatory cytokine and chemokine production by NK cells, which may lead to activation and recruitment of macrophages at the tumor site. Thus, this report provides further insight into the function of CRCL as an immunostimulant against cancer. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:2624 / 2631
页数:8
相关论文
共 31 条
  • [1] Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunity
    Chen, XC
    Zeng, Y
    Li, G
    Larmonier, N
    Graner, MW
    Katsanis, E
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (03) : 275 - 283
  • [2] Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity
    Zeng, Y
    Feng, HP
    Graner, MW
    Katsanis, E
    BLOOD, 2003, 101 (11) : 4485 - 4491
  • [3] Natural killer T (NKT) cells and their role in antitumor immunity
    Brutkiewicz, RR
    Sriram, V
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 41 (03) : 287 - 298
  • [4] Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression
    Larmonier, Nicolas
    Cantrell, Jessica
    LaCasse, Collin
    Li, Gang
    Janikashvili, Nona
    Situ, Elaine
    Sepassi, Marjan
    Andreansky, Samita
    Katsanis, Emmanuel
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (04) : 1049 - 1059
  • [5] Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells
    Zeng, Y
    Graner, MW
    Thompson, S
    Marron, M
    Katsanis, E
    BLOOD, 2005, 105 (05) : 2016 - 2022
  • [6] Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia
    Zeng, Y
    Graner, MW
    Feng, HP
    Li, G
    Katsanis, E
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) : 251 - 259
  • [7] The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity
    Graner, Michael W.
    Romanoski, Angela
    Katsanis, Emmanuel
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (05) : 380 - 389
  • [8] Imatinib mesylate effectively combines with chaperone-rich cell lysate loaded dendritic cells to treat bcr-abl+ murine leukemia.
    Zeng, Y
    Graner, MW
    Feng, HP
    Li, G
    Katsanis, E
    BLOOD, 2003, 102 (11) : 322B - 322B
  • [9] NATURAL-KILLER CELLS - ROLE IN CELL-MEDIATED-IMMUNITY
    GOLDFARB, RH
    BERENDT, MJ
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1983, 18 : 265 - 273
  • [10] Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18
    Hashimoto, W
    Tanaka, F
    Robbins, PD
    Taniguchi, M
    Okamura, H
    Lotze, MT
    Tahara, H
    INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (04) : 508 - 513